Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TONKA vs Silymarin for Elevated Liver Enzymes
NCT03216668Phase 3Unknown
- Sponsor
- Nhat Nhat Pharmaceutical Company Limited
- Start
- Jun 2017
- Primary completion
- Jun 2019
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of TONKA in alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), drug induced liver injury (DILI), sponsored by Nhat Nhat Pharmaceutical Company Limited. Status: unknown.
02
Drugs
TONKA
03
Conditions
alcoholic liver disease (ALD)non-alcoholic fatty liver disease (NAFLD)drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT03216668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216668.